Pacific Biosciences Of California (PACB) Shares Outstanding (2010 - 2026)
Pacific Biosciences Of California (PACB) Shares Outstanding (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn | 305.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305.82 Mn |
| Dec 31, 2025 | 299.96 Mn |
| Sep 30, 2025 | 300.84 Mn |
| Jun 30, 2025 | 300.16 Mn |
| Mar 31, 2025 | 296.86 Mn |
| Dec 31, 2024 | 274.49 Mn |
| Sep 30, 2024 | 272.92 Mn |
| Jun 30, 2024 | 272.39 Mn |
| Mar 31, 2024 | 269.58 Mn |
| Dec 31, 2023 | 253.63 Mn |
| Sep 30, 2023 | 255.00 Mn |
| Jun 30, 2023 | 250.07 Mn |
| Mar 31, 2023 | 242.03 Mn |
| Dec 31, 2022 | 224.55 Mn |
| Sep 30, 2022 | 225.12 Mn |
| Jun 30, 2022 | 224.50 Mn |
| Mar 31, 2022 | 222.29 Mn |
| Dec 31, 2021 | 204.14 Mn |
| Sep 20, 2021 | 198.57 Mn |
| Jun 30, 2021 | 198.57 Mn |